Highlights of ASH in North America

Last Modified: January 17, 2013

Dates: January 18-19, 2013; January 25-26, 2013; February 1-2, 2013
Location: Multiple locations

Sponsoring Group: The American Society of Hematology

Web Page URL: www.hematology.org/calendar_HOANA

Topics Covered: Myelodysplastic Syndromes Acute Myeloid Leukemia Myeloproliferative Neoplasms including Chronic Myeloid Leukemia Hematopoietic Stem Cell Transplantation Non-Hodgkin Lymphoma Disorders of Hemostasis Thrombosis and Anticoagulation Thrombotic Thrombocytopenic Purpura (TTP)/Hemolytic Uremic Syndrome (HUS) and Atypical HUS Novel Treatments for Relapsed/Refractory Chronic Immune Thrombocytopenia Bone Marrow Failure Chronic Lymphocytic Leukemia Plasma Cell Disorders (Myeloma)

Objectives: The eighth official Highlights of ASH will feature leading hematology experts who will present unbiased analysis of the 54th ASH Annual Meeting abstracts and sessions,including evolving therapies, the latest treatment options, and their clinical applications.

Fees: $175-$225

Continuing Education: Yes


Hand Washing Saves Patients' Lives
by Rodney Warner, JD
January 20, 2015

Medicinal Mushrooms – Support and Safety During Breast Cancer
by The 4Wholeness Team
September 29, 2015

Related News

ASH: Hodgkin's Lymphoma Tx Shows Promise in Small Trial

Dec 9, 2014

Nivolumab harnesses power of immune system in patients who've failed other therapy

ASH: Carfilzomib Ups Survival in Relapsed Multiple Myeloma

Dec 9, 2014

Improved progression-free survival with addition of carfilzomib to lenalidomide and dexamethasone

ASH: CALR Mutations ID'd in Myeloproliferative Neoplasms

Dec 11, 2013

Two studies show somatic mutations in CALR for most patients with nonmutated JAK2